{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,23]],"date-time":"2026-09-23T19:11:55Z","timestamp":1790190715187,"version":"4.1.0"},"reference-count":144,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2015,8,1]],"date-time":"2015-08-01T00:00:00Z","timestamp":1438387200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"funder":[{"DOI":"10.13039\/501100004243","name":"Prinses Beatrix Spierfonds","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100004243","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100013428","name":"Stichting Spieren voor Spieren","doi-asserted-by":"crossref","id":[{"id":"10.13039\/501100013428","id-type":"DOI","asserted-by":"crossref"}]},{"name":"L'Association Fran\u00e7aise contre les myopathies"},{"name":"Muscular Dystrophy Association (USA)"},{"name":"National Health and Medical Research Council (Australia)"}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Experimental Neurology"],"published-print":{"date-parts":[[2015,8]]},"DOI":"10.1016\/j.expneurol.2015.01.007","type":"journal-article","created":{"date-parts":[[2015,1,23]],"date-time":"2015-01-23T02:31:55Z","timestamp":1421980315000},"page":"41-54","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":60,"special_numbering":"C","title":["Electrophysiological analysis of neuromuscular synaptic function in myasthenia gravis patients and animal models"],"prefix":"10.1016","volume":"270","author":[{"given":"Jaap J.","family":"Plomp","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Marco","family":"Morsch","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"William D.","family":"Phillips","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jan J.G.M.","family":"Verschuuren","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.expneurol.2015.01.007_bb0005","doi-asserted-by":"crossref","first-page":"536","DOI":"10.1016\/0014-4886(76)90179-5","article-title":"An electrophysiological and morphological study of the neuromuscular junction in patients with myasthenia gravis","volume":"51","author":"Albuquerque","year":"1976","journal-title":"Exp. Neurol."},{"key":"10.1016\/j.expneurol.2015.01.007_bb0010","doi-asserted-by":"crossref","first-page":"83","DOI":"10.1016\/0304-3940(87)90175-3","article-title":"The levator auris longus muscle of the mouse: a convenient preparation for studies of short- and long-term presynaptic effects of drugs or toxins","volume":"82","author":"Angaut-Petit","year":"1987","journal-title":"Neurosci. Lett."},{"key":"10.1016\/j.expneurol.2015.01.007_bb0015","doi-asserted-by":"crossref","first-page":"19","DOI":"10.1007\/s00005-011-0158-6","article-title":"Acetylcholine receptor-induced experimental myasthenia gravis: what have we learned from animal models after three decades?","volume":"60","author":"Baggi","year":"2012","journal-title":"Arch. Immunol. Ther. Exp. (Warsz)"},{"key":"10.1016\/j.expneurol.2015.01.007_bb0020","doi-asserted-by":"crossref","first-page":"275","DOI":"10.1007\/s10974-007-9118-5","article-title":"Bridging the myoplasmic gap: recent developments in skeletal muscle excitation\u2013contraction coupling","volume":"28","author":"Bannister","year":"2007","journal-title":"J. Muscle Res. Cell Motil."},{"key":"10.1016\/j.expneurol.2015.01.007_bb0025","doi-asserted-by":"crossref","first-page":"13892","DOI":"10.1523\/JNEUROSCI.1733-14.2014","article-title":"LRP4 is critical for neuromuscular junction maintenance","volume":"34","author":"Barik","year":"2014","journal-title":"J. Neurosci."},{"key":"10.1016\/j.expneurol.2015.01.007_bb0030","doi-asserted-by":"crossref","first-page":"459","DOI":"10.1016\/j.nmd.2006.05.006","article-title":"A systematic review of diagnostic studies in myasthenia gravis","volume":"16","author":"Benatar","year":"2006","journal-title":"Neuromuscul. Disord."},{"key":"10.1016\/j.expneurol.2015.01.007_bb0035","first-page":"3P","article-title":"The epitrochleoanconeus muscle (ETA) of the mouse: a useful muscle for the study of motor innervation in vitro","volume":"415","author":"Bradley","year":"1989","journal-title":"J. Physiol."},{"key":"10.1016\/j.expneurol.2015.01.007_bb0040","doi-asserted-by":"crossref","first-page":"619","DOI":"10.1113\/jphysiol.1982.sp014472","article-title":"Presynaptic currents in mouse motor endings","volume":"333","author":"Brigant","year":"1982","journal-title":"J. Physiol."},{"key":"10.1016\/j.expneurol.2015.01.007_bb0045","doi-asserted-by":"crossref","first-page":"1351","DOI":"10.1084\/jem.166.5.1351","article-title":"Comparison of the effector functions of human immunoglobulins using a matched set of chimeric antibodies","volume":"166","author":"Bruggemann","year":"1987","journal-title":"J. Exp. Med."},{"key":"10.1016\/j.expneurol.2015.01.007_bb0050","doi-asserted-by":"crossref","first-page":"1393","DOI":"10.1002\/mus.880171208","article-title":"Passive transfer of seronegative myasthenia gravis to mice","volume":"17","author":"Burges","year":"1994","journal-title":"Muscle Nerve"},{"key":"10.1016\/j.expneurol.2015.01.007_bb0055","doi-asserted-by":"crossref","first-page":"618","DOI":"10.1016\/j.neuron.2014.03.012","article-title":"Miniature neurotransmission regulates Drosophila synaptic structural maturation","volume":"82","author":"Choi","year":"2014","journal-title":"Neuron"},{"key":"10.1016\/j.expneurol.2015.01.007_bb0060","doi-asserted-by":"crossref","first-page":"150","DOI":"10.1016\/j.jns.2011.12.016","article-title":"Neurophysiological characteristics of MuSK antibody positive myasthenia gravis mice: focal denervation and hypersensitivity to acetylcholinesterase inhibitors","volume":"316","author":"Chroni","year":"2012","journal-title":"J. Neurol. Sci."},{"key":"10.1016\/j.expneurol.2015.01.007_bb0065","doi-asserted-by":"crossref","first-page":"12","DOI":"10.3389\/fnmol.2012.00012","article-title":"Presynaptic active zone density during development and synaptic plasticity","volume":"5","author":"Clarke","year":"2012","journal-title":"Front. Mol. Neurosci."},{"key":"10.1016\/j.expneurol.2015.01.007_bb0070","doi-asserted-by":"crossref","first-page":"782","DOI":"10.1002\/ana.21371","article-title":"Anti-MuSK patient antibodies disrupt the mouse neuromuscular junction","volume":"63","author":"Cole","year":"2008","journal-title":"Ann. Neurol."},{"key":"10.1016\/j.expneurol.2015.01.007_bb0075","doi-asserted-by":"crossref","first-page":"464","DOI":"10.1038\/294464a0","article-title":"Fluctuations in the microsecond time range of the current through single acetylcholine receptor ion channels","volume":"294","author":"Colquhoun","year":"1981","journal-title":"Nature"},{"key":"10.1016\/j.expneurol.2015.01.007_bb0080","doi-asserted-by":"crossref","first-page":"17","DOI":"10.1016\/0014-2999(73)90177-5","article-title":"Ketamine: myoneural activity and interaction with neuromuscular blocking agents","volume":"22","author":"Cronnelly","year":"1973","journal-title":"Eur. J. Pharmacol."},{"key":"10.1016\/j.expneurol.2015.01.007_bb0085","doi-asserted-by":"crossref","first-page":"74","DOI":"10.1038\/271074a0","article-title":"Acetylcholine-induced channels and transmitter release at human endplates","volume":"271","author":"Cull-Candy","year":"1978","journal-title":"Nature"},{"key":"10.1016\/j.expneurol.2015.01.007_bb0090","doi-asserted-by":"crossref","first-page":"621","DOI":"10.1113\/jphysiol.1980.sp013145","article-title":"On the release of transmitter at normal, myasthenia gravis and myasthenic syndrome affected human end-plates","volume":"299","author":"Cull-Candy","year":"1980","journal-title":"J. Physiol."},{"key":"10.1016\/j.expneurol.2015.01.007_bb0095","doi-asserted-by":"crossref","first-page":"336","DOI":"10.1113\/jphysiol.1961.sp006679","article-title":"An electrophysiologic study of the neuromuscular junction in myasthenia gravis","volume":"156","author":"Dahlback","year":"1961","journal-title":"J. Physiol."},{"key":"10.1016\/j.expneurol.2015.01.007_bb0100","doi-asserted-by":"crossref","first-page":"718","DOI":"10.1016\/j.neuron.2013.09.044","article-title":"Homeostatic signaling and the stabilization of neural function","volume":"80","author":"Davis","year":"2013","journal-title":"Neuron"},{"key":"10.1016\/j.expneurol.2015.01.007_bb0105","doi-asserted-by":"crossref","first-page":"365","DOI":"10.1152\/jn.1998.80.1.365","article-title":"Spontaneous electromyographic activity in adult rat soleus muscle","volume":"80","author":"Eken","year":"1998","journal-title":"J. Neurophysiol."},{"key":"10.1016\/j.expneurol.2015.01.007_bb0115","doi-asserted-by":"crossref","first-page":"602","DOI":"10.1113\/jphysiol.1960.sp006599","article-title":"A study of some electrophysiological properties of human intercostal muscle","volume":"154","author":"Elmqvist","year":"1960","journal-title":"J. Physiol."},{"key":"10.1016\/j.expneurol.2015.01.007_bb0110","doi-asserted-by":"crossref","first-page":"417","DOI":"10.1113\/jphysiol.1964.sp007495","article-title":"An electrophysiological investigation of neuromuscular transmission in myasthenia gravis","volume":"174","author":"Elmqvist","year":"1964","journal-title":"J. Physiol."},{"key":"10.1016\/j.expneurol.2015.01.007_bb0120","doi-asserted-by":"crossref","first-page":"99","DOI":"10.1016\/j.nmd.2011.10.009","article-title":"Current status of the congenital myasthenic syndromes","volume":"22","author":"Engel","year":"2012","journal-title":"Neuromuscul. Disord."},{"key":"10.1016\/j.expneurol.2015.01.007_bb0135","doi-asserted-by":"crossref","first-page":"569","DOI":"10.1097\/00005072-197609000-00008","article-title":"Experimental autoimmune myasthenia gravis: a sequential and quantitative study of the neuromuscular junction ultrastructure and electrophysiologic correlations","volume":"35","author":"Engel","year":"1976","journal-title":"J. Neuropathol. Exp. Neurol."},{"key":"10.1016\/j.expneurol.2015.01.007_bb0125","doi-asserted-by":"crossref","first-page":"307","DOI":"10.1212\/WNL.27.4.307","article-title":"Ultrastructural localization of the acetylcholine receptor in myasthenia gravis and in its experimental autoimmune model","volume":"27","author":"Engel","year":"1977","journal-title":"Neurology"},{"key":"10.1016\/j.expneurol.2015.01.007_bb0130","doi-asserted-by":"crossref","first-page":"140","DOI":"10.1111\/j.1749-6632.1998.tb10921.x","article-title":"Congenital myasthenic syndromes. New insights from molecular genetic and patch-clamp studies","volume":"841","author":"Engel","year":"1998","journal-title":"Ann. N. Y. Acad. Sci."},{"key":"10.1016\/j.expneurol.2015.01.007_bb0140","doi-asserted-by":"crossref","first-page":"2304","DOI":"10.1093\/brain\/awg223","article-title":"Clinical correlates with anti-MuSK antibodies in generalized seronegative myasthenia gravis","volume":"126","author":"Evoli","year":"2003","journal-title":"Brain"},{"key":"10.1016\/j.expneurol.2015.01.007_bb0145","doi-asserted-by":"crossref","first-page":"293","DOI":"10.1126\/science.182.4109.293","article-title":"Neuromuscular junction in myasthenia gravis: decreased acetylcholine receptors","volume":"182","author":"Fambrough","year":"1973","journal-title":"Science"},{"key":"10.1016\/j.expneurol.2015.01.007_bb0150","doi-asserted-by":"crossref","first-page":"579","DOI":"10.1002\/mus.21151","article-title":"Concentric and single fiber needle electrodes yield comparable jitter results in myasthenia gravis","volume":"39","author":"Farrugia","year":"2009","journal-title":"Muscle Nerve"},{"key":"10.1016\/j.expneurol.2015.01.007_bb0155","doi-asserted-by":"crossref","first-page":"63","DOI":"10.1016\/j.neuropharm.2013.06.015","article-title":"Homeostatic plasticity at the Drosophila neuromuscular junction","volume":"78","author":"Frank","year":"2014","journal-title":"Neuropharmacology"},{"key":"10.1016\/j.expneurol.2015.01.007_bb0165","doi-asserted-by":"crossref","first-page":"244","DOI":"10.1196\/annals.1405.032","article-title":"Immunosuppression of EAMG by IVIG is mediated by a disease-specific anti-immunoglobulin fraction","volume":"1132","author":"Fuchs","year":"2008","journal-title":"Ann. N. Y. Acad. Sci."},{"key":"10.1016\/j.expneurol.2015.01.007_bb0160","doi-asserted-by":"crossref","first-page":"51","DOI":"10.1016\/j.jaut.2014.06.003","article-title":"Experimental autoimmune myasthenia gravis (EAMG): from immunochemical characterization to therapeutic approaches","volume":"54","author":"Fuchs","year":"2014","journal-title":"J. Autoimmun."},{"key":"10.1016\/j.expneurol.2015.01.007_bb0170","doi-asserted-by":"crossref","first-page":"35","DOI":"10.1113\/jphysiol.2006.108092","article-title":"The human adult subtype ACh receptor channel has high Ca2+ permeability and predisposes to endplate Ca2+ overloading","volume":"573","author":"Fucile","year":"2006","journal-title":"J. Physiol."},{"key":"10.1016\/j.expneurol.2015.01.007_bb0175","doi-asserted-by":"crossref","first-page":"1976","DOI":"10.1212\/WNL.0000000000000478","article-title":"Anti-agrin autoantibodies in myasthenia gravis","volume":"82","author":"Gasperi","year":"2014","journal-title":"Neurology"},{"key":"10.1016\/j.expneurol.2015.01.007_bb0180","doi-asserted-by":"crossref","first-page":"295","DOI":"10.1016\/j.biocel.2010.10.008","article-title":"Muscle specific kinase: organiser of synaptic membrane domains","volume":"43","author":"Ghazanfari","year":"2011","journal-title":"Int. J. Biochem. Cell Biol."},{"key":"10.1016\/j.expneurol.2015.01.007_bb0185","doi-asserted-by":"crossref","first-page":"2881","DOI":"10.1113\/jphysiol.2013.270207","article-title":"Muscle-specific kinase (MuSK) autoantibodies suppress the MuSK pathway and ACh receptor retention at the mouse neuromuscular junction","volume":"592","author":"Ghazanfari","year":"2014","journal-title":"J. Physiol."},{"key":"10.1016\/j.expneurol.2015.01.007_bb0190","doi-asserted-by":"crossref","first-page":"e87840","DOI":"10.1371\/journal.pone.0087840","article-title":"Effects of the beta2-adrenoceptor agonist, albuterol, in a mouse model of anti-MuSK myasthenia gravis","volume":"9","author":"Ghazanfari","year":"2014","journal-title":"PLoS One"},{"key":"10.1016\/j.expneurol.2015.01.007_bb0195","doi-asserted-by":"crossref","first-page":"36","DOI":"10.1002\/mus.22006","article-title":"Anti-musk antibody myasthenia gravis: clinical findings and response to treatment in two large cohorts","volume":"44","author":"Guptill","year":"2011","journal-title":"Muscle Nerve"},{"key":"10.1016\/j.expneurol.2015.01.007_bb0200","doi-asserted-by":"crossref","first-page":"164","DOI":"10.1038\/314164a0","article-title":"Firing patterns of motor units in normal rats","volume":"314","author":"Hennig","year":"1985","journal-title":"Nature"},{"key":"10.1016\/j.expneurol.2015.01.007_bb0205","doi-asserted-by":"crossref","first-page":"470","DOI":"10.1016\/j.mcn.2005.10.020","article-title":"Synapse disassembly and formation of new synapses in postnatal muscle upon conditional inactivation of MuSK","volume":"31","author":"Hesser","year":"2006","journal-title":"Mol. Cell. Neurosci."},{"key":"10.1016\/j.expneurol.2015.01.007_bb0210","doi-asserted-by":"crossref","first-page":"418","DOI":"10.1002\/ana.22312","article-title":"Autoantibodies to low-density lipoprotein receptor-related protein 4 in myasthenia gravis","volume":"69","author":"Higuchi","year":"2011","journal-title":"Ann. Neurol."},{"key":"10.1016\/j.expneurol.2015.01.007_bb0215","doi-asserted-by":"crossref","first-page":"365","DOI":"10.1038\/85520","article-title":"Auto-antibodies to the receptor tyrosine kinase MuSK in patients with myasthenia gravis without acetylcholine receptor antibodies","volume":"7","author":"Hoch","year":"2001","journal-title":"Nat. Med."},{"key":"10.1016\/j.expneurol.2015.01.007_bb0220","doi-asserted-by":"crossref","first-page":"169","DOI":"10.1016\/j.pmr.2012.08.013","article-title":"Electrodiagnosis of disorders of neuromuscular transmission","volume":"24","author":"Howard","year":"2013","journal-title":"Phys. Med. Rehabil. Clin. N. Am."},{"key":"10.1016\/j.expneurol.2015.01.007_bb9000","doi-asserted-by":"crossref","first-page":"111","DOI":"10.1016\/j.jneuroim.2008.05.029","article-title":"Immunosuppression of experimental autoimmune myasthenia gravis by mycophenolate mofetil","volume":"201\u2013202","author":"Janssen","year":"2008","journal-title":"J. Neuroimmunol."},{"key":"10.1016\/j.expneurol.2015.01.007_bb0225","doi-asserted-by":"crossref","first-page":"107","DOI":"10.1016\/j.jneuroim.2006.03.016","article-title":"Myasthenia gravis induced in mice by immunization with the recombinant extracellular domain of rat muscle-specific kinase (MuSK)","volume":"175","author":"Jha","year":"2006","journal-title":"J. Neuroimmunol."},{"key":"10.1016\/j.expneurol.2015.01.007_bb0230","doi-asserted-by":"crossref","first-page":"81","DOI":"10.1016\/j.neuroscience.2005.04.069","article-title":"Gene dosage-dependent transmitter release changes at neuromuscular synapses of CACNA1A R192Q knockin mice are non-progressive and do not lead to morphological changes or muscle weakness","volume":"135","author":"Kaja","year":"2005","journal-title":"Neuroscience"},{"key":"10.1016\/j.expneurol.2015.01.007_bb0235","doi-asserted-by":"crossref","first-page":"2009","DOI":"10.1111\/j.1460-9568.2007.05438.x","article-title":"Severely impaired neuromuscular synaptic transmission causes muscle weakness in the Cacna1a-mutant mouse rolling Nagoya","volume":"25","author":"Kaja","year":"2007","journal-title":"Eur. J. Neurosci."},{"key":"10.1016\/j.expneurol.2015.01.007_bb0240","doi-asserted-by":"crossref","first-page":"1081","DOI":"10.1093\/brain\/aws025","article-title":"Muscle-specific kinase myasthenia gravis IgG4 autoantibodies cause severe neuromuscular junction dysfunction in mice","volume":"135","author":"Klooster","year":"2012","journal-title":"Brain"},{"key":"10.1016\/j.expneurol.2015.01.007_bb0245","doi-asserted-by":"crossref","first-page":"29","DOI":"10.1111\/joa.12034","article-title":"The role of muscle-specific tyrosine kinase (MuSK) and mystery of MuSK myasthenia gravis","volume":"224","author":"Koneczny","year":"2014","journal-title":"J. Anat."},{"key":"10.1016\/j.expneurol.2015.01.007_bb0250","doi-asserted-by":"crossref","first-page":"1940","DOI":"10.1093\/brain\/awn092","article-title":"IgG1 antibodies to acetylcholine receptors in \u2018seronegative\u2019 myasthenia gravis","volume":"131","author":"Leite","year":"2008","journal-title":"Brain"},{"key":"10.1016\/j.expneurol.2015.01.007_bb0255","doi-asserted-by":"crossref","first-page":"238","DOI":"10.1038\/285238a0","article-title":"Myasthenia gravis induced by monoclonal antibodies to acetylcholine receptors","volume":"285","author":"Lennon","year":"1980","journal-title":"Nature"},{"key":"10.1016\/j.expneurol.2015.01.007_bb0260","doi-asserted-by":"crossref","first-page":"1365","DOI":"10.1084\/jem.141.6.1365","article-title":"Experimental autoimmune myasthenia: a model of myasthenia gravis in rats and guinea pigs","volume":"141","author":"Lennon","year":"1975","journal-title":"J. Exp. Med."},{"key":"10.1016\/j.expneurol.2015.01.007_bb0265","doi-asserted-by":"crossref","first-page":"628","DOI":"10.1002\/(SICI)1097-4598(199805)21:5<628::AID-MUS9>3.0.CO;2-A","article-title":"Characterization of the relationship between motor end-plate jitter and the safety factor","volume":"21","author":"Lin","year":"1998","journal-title":"Muscle Nerve"},{"key":"10.1016\/j.expneurol.2015.01.007_bb0270","doi-asserted-by":"crossref","first-page":"1920","DOI":"10.1212\/01.WNL.0000129702.41868.A5","article-title":"Is \u201cseronegative\u201d MG explained by autoantibodies to MuSK?","volume":"62","author":"Lindstrom","year":"2004","journal-title":"Neurology"},{"key":"10.1016\/j.expneurol.2015.01.007_bb0275","doi-asserted-by":"crossref","first-page":"1189","DOI":"10.1002\/mus.880141208","article-title":"Anconeus muscle: a human muscle preparation suitable for in-vitro microelectrode studies","volume":"14","author":"Maselli","year":"1991","journal-title":"Muscle Nerve"},{"key":"10.1016\/j.expneurol.2015.01.007_bb0280","doi-asserted-by":"crossref","first-page":"1497","DOI":"10.1212\/WNL.41.9.1497","article-title":"Inflammation at the neuromuscular junction in myasthenia gravis","volume":"41","author":"Maselli","year":"1991","journal-title":"Neurology"},{"key":"10.1016\/j.expneurol.2015.01.007_bb0285","doi-asserted-by":"crossref","first-page":"109","DOI":"10.1016\/0165-0270(81)90044-3","article-title":"Advantages of the triangularis sterni muscle of the mouse for investigations of synaptic phenomena","volume":"4","author":"McArdle","year":"1981","journal-title":"J. Neurosci. Methods"},{"key":"10.1016\/j.expneurol.2015.01.007_bb0290","doi-asserted-by":"crossref","first-page":"580","DOI":"10.1002\/ana.20061","article-title":"Detection and characterization of MuSK antibodies in seronegative myasthenia gravis","volume":"55","author":"McConville","year":"2004","journal-title":"Ann. Neurol."},{"key":"10.1016\/j.expneurol.2015.01.007_bb0295","doi-asserted-by":"crossref","first-page":"307","DOI":"10.1113\/jphysiol.1981.sp013586","article-title":"Non-linear summation of end-plate potentials in the frog and mouse","volume":"311","author":"McLachlan","year":"1981","journal-title":"J. Physiol."},{"key":"10.1016\/j.expneurol.2015.01.007_bb0300","doi-asserted-by":"crossref","first-page":"627","DOI":"10.1097\/01.phm.0000171169.79816.4c","article-title":"Advances in the diagnosis of neuromuscular junction disorders","volume":"84","author":"Meriggioli","year":"2005","journal-title":"Am. J. Phys. Med. Rehabil."},{"key":"10.1016\/j.expneurol.2015.01.007_bb0305","doi-asserted-by":"crossref","first-page":"3159","DOI":"10.1113\/jphysiol.2012.248625","article-title":"Organization and function of transmitter release sites at the neuromuscular junction","volume":"591","author":"Meriney","year":"2013","journal-title":"J. Physiol."},{"key":"10.1016\/j.expneurol.2015.01.007_bb0315","doi-asserted-by":"crossref","first-page":"720","DOI":"10.1136\/jnnp.56.6.720-a","article-title":"Ocular myasthenia: diagnostic value of single fibre EMG in the orbicularis oculi muscle","volume":"56","author":"Milone","year":"1993","journal-title":"J. Neurol. Neurosurg. Psychiatry"},{"key":"10.1016\/j.expneurol.2015.01.007_bb0310","doi-asserted-by":"crossref","first-page":"1364","DOI":"10.1002\/mus.880171204","article-title":"Patch-clamp analysis of the properties of acetylcholine receptor channels at the normal human endplate","volume":"17","author":"Milone","year":"1994","journal-title":"Muscle Nerve"},{"key":"10.1016\/j.expneurol.2015.01.007_bb0325","doi-asserted-by":"crossref","first-page":"449","DOI":"10.1016\/S0079-6123(08)64657-9","article-title":"Acetylcholine in intercostal muscle from myasthenia gravis patients and in rat diaphragm after blockade of acetylcholine receptors","volume":"49","author":"Molenaar","year":"1979","journal-title":"Prog. Brain Res."},{"key":"10.1016\/j.expneurol.2015.01.007_bb0320","doi-asserted-by":"crossref","first-page":"93","DOI":"10.1016\/0014-2999(91)90413-K","article-title":"A non-immunogenic myasthenia gravis model and its application in a study of transsynaptic regulation at the neuromuscular junction","volume":"196","author":"Molenaar","year":"1991","journal-title":"Eur. J. Pharmacol."},{"key":"10.1016\/j.expneurol.2015.01.007_bb0330","doi-asserted-by":"crossref","first-page":"75","DOI":"10.1016\/j.jneuroim.2012.02.010","article-title":"3,4-Diaminopyridine improves neuromuscular transmission in a MuSK antibody-induced mouse model of myasthenia gravis","volume":"245","author":"Mori","year":"2012","journal-title":"J. Neuroimmunol."},{"key":"10.1016\/j.expneurol.2015.01.007_bb0335","doi-asserted-by":"crossref","first-page":"798","DOI":"10.1016\/j.ajpath.2011.10.031","article-title":"Antibodies against muscle-specific kinase impair both presynaptic and postsynaptic functions in a murine model of myasthenia gravis","volume":"180","author":"Mori","year":"2012","journal-title":"Am. J. Pathol."},{"key":"10.1016\/j.expneurol.2015.01.007_bb0340","doi-asserted-by":"crossref","first-page":"286","DOI":"10.1016\/j.expneurol.2012.06.034","article-title":"Muscle specific kinase autoantibodies cause synaptic failure through progressive wastage of postsynaptic acetylcholine receptors","volume":"237","author":"Morsch","year":"2012","journal-title":"Exp. Neurol."},{"key":"10.1016\/j.expneurol.2015.01.007_bb0345","doi-asserted-by":"crossref","first-page":"2747","DOI":"10.1113\/jphysiol.2013.251827","article-title":"Pyridostigmine but not 3,4-diaminopyridine exacerbates ACh receptor loss and myasthenia induced in mice by muscle-specific kinase autoantibody","volume":"591","author":"Morsch","year":"2013","journal-title":"J. Physiol."},{"key":"10.1016\/j.expneurol.2015.01.007_bb0350","doi-asserted-by":"crossref","first-page":"457","DOI":"10.1002\/cne.21975","article-title":"Macromolecular connections of active zone material to docked synaptic vesicles and presynaptic membrane at neuromuscular junctions of mouse","volume":"513","author":"Nagwaney","year":"2009","journal-title":"J. Comp. Neurol."},{"issue":"Pt 3","key":"10.1016\/j.expneurol.2015.01.007_bb0355","doi-asserted-by":"crossref","first-page":"767","DOI":"10.1113\/jphysiol.1995.sp021090","article-title":"Functional and non-functional isoforms of the human muscle acetylcholine receptor","volume":"489","author":"Newland","year":"1995","journal-title":"J. Physiol."},{"key":"10.1016\/j.expneurol.2015.01.007_bb0360","doi-asserted-by":"crossref","first-page":"236","DOI":"10.1002\/mus.10411","article-title":"Decremental response of the nasalis and hypothenar muscles in myasthenia gravis","volume":"28","author":"Niks","year":"2003","journal-title":"Muscle Nerve"},{"key":"10.1016\/j.expneurol.2015.01.007_bb0365","doi-asserted-by":"crossref","first-page":"283","DOI":"10.1002\/mus.21642","article-title":"Pre- and postsynaptic neuromuscular junction abnormalities in musk myasthenia","volume":"42","author":"Niks","year":"2010","journal-title":"Muscle Nerve"},{"key":"10.1016\/j.expneurol.2015.01.007_bb0370","doi-asserted-by":"crossref","first-page":"24","DOI":"10.1111\/j.1749-6632.2012.06836.x","article-title":"Active zones of mammalian neuromuscular junctions: formation, density, and aging","volume":"1274","author":"Nishimune","year":"2012","journal-title":"Ann. N. Y. Acad. Sci."},{"key":"10.1016\/j.expneurol.2015.01.007_bb0375","doi-asserted-by":"crossref","first-page":"e38029","DOI":"10.1371\/journal.pone.0038029","article-title":"Active zone protein Bassoon co-localizes with presynaptic calcium channel, modifies channel function, and recovers from aging related loss by exercise","volume":"7","author":"Nishimune","year":"2012","journal-title":"PLoS One"},{"key":"10.1016\/j.expneurol.2015.01.007_bb0380","doi-asserted-by":"crossref","first-page":"142","DOI":"10.1002\/mus.880160204","article-title":"Ocular myasthenia gravis: the diagnostic yield of repetitive nerve stimulation and stimulated single fiber EMG of orbicularis oculi muscle and infrared reflection oculography","volume":"16","author":"Oey","year":"1993","journal-title":"Muscle Nerve"},{"key":"10.1016\/j.expneurol.2015.01.007_bb0385","doi-asserted-by":"crossref","first-page":"500","DOI":"10.1002\/mus.20498","article-title":"Repetitive nerve stimulation of facial muscles in MuSK antibody-positive myasthenia gravis","volume":"33","author":"Oh","year":"2006","journal-title":"Muscle Nerve"},{"key":"10.1016\/j.expneurol.2015.01.007_bb0390","doi-asserted-by":"crossref","first-page":"753","DOI":"10.1093\/hmg\/6.5.753","article-title":"Congenital myasthenic syndromes due to heteroallelic nonsense\/missense mutations in the acetylcholine receptor epsilon subunit gene: identification and functional characterization of six new mutations","volume":"6","author":"Ohno","year":"1997","journal-title":"Hum. Mol. Genet."},{"key":"10.1016\/j.expneurol.2015.01.007_bb0395","doi-asserted-by":"crossref","first-page":"1029","DOI":"10.1111\/j.1468-1331.2007.01870.x","article-title":"Clinical and experimental features of MuSK antibody positive MG in Japan","volume":"14","author":"Ohta","year":"2007","journal-title":"Eur. J. Neurol."},{"key":"10.1016\/j.expneurol.2015.01.007_bb0400","first-page":"4","article-title":"Decoding pathogenesis of slow-channel congenital myasthenic syndromes using recombinant expression and mice models","volume":"29","author":"Otero-Cruz","year":"2010","journal-title":"P. R. Health Sci. J."},{"key":"10.1016\/j.expneurol.2015.01.007_bb0410","doi-asserted-by":"crossref","first-page":"1203","DOI":"10.1016\/S1388-2457(00)00307-2","article-title":"SFEMG in ocular myasthenia gravis diagnosis","volume":"111","author":"Padua","year":"2000","journal-title":"Clin. Neurophysiol."},{"key":"10.1016\/j.expneurol.2015.01.007_bb0405","doi-asserted-by":"crossref","first-page":"1270","DOI":"10.1016\/j.clinph.2013.11.005","article-title":"Reliability of SFEMG in diagnosing myasthenia gravis: sensitivity and specificity calculated on 100 prospective cases","volume":"125","author":"Padua","year":"2014","journal-title":"Clin. Neurophysiol."},{"key":"10.1016\/j.expneurol.2015.01.007_bb0415","doi-asserted-by":"crossref","first-page":"1437","DOI":"10.1016\/j.clinph.2011.10.046","article-title":"A comparison between disposable and reusable single fiber needle electrodes in relation to stimulated single fiber studies","volume":"123","author":"Papathanasiou","year":"2012","journal-title":"Clin. Neurophysiol."},{"key":"10.1016\/j.expneurol.2015.01.007_bb0420","doi-asserted-by":"crossref","first-page":"871","DOI":"10.1126\/science.180.4088.871","article-title":"Autoimmune response to acetylcholine receptor","volume":"180","author":"Patrick","year":"1973","journal-title":"Science"},{"key":"10.1016\/j.expneurol.2015.01.007_bb0425","doi-asserted-by":"crossref","first-page":"427","DOI":"10.1007\/s00415-011-6194-7","article-title":"Anti-LRP4 autoantibodies in AChR- and MuSK-antibody-negative myasthenia gravis","volume":"259","author":"Pevzner","year":"2012","journal-title":"J. Neurol."},{"key":"10.1016\/j.expneurol.2015.01.007_bb0430","doi-asserted-by":"crossref","first-page":"173","DOI":"10.1016\/S0165-5728(96)00144-0","article-title":"Soluble complement receptor 1 (sCR1) protects against experimental autoimmune myasthenia gravis","volume":"71","author":"Piddlesden","year":"1996","journal-title":"J. Neuroimmunol."},{"key":"10.1016\/j.expneurol.2015.01.007_bb0440","doi-asserted-by":"crossref","first-page":"487","DOI":"10.1113\/jphysiol.1992.sp019429","article-title":"Adaptation of quantal content to decreased postsynaptic sensitivity at single endplates in alpha-bungarotoxin-treated rats","volume":"458","author":"Plomp","year":"1992","journal-title":"J. Physiol."},{"issue":"Pt 1","key":"10.1016\/j.expneurol.2015.01.007_bb0445","doi-asserted-by":"crossref","first-page":"125","DOI":"10.1113\/jphysiol.1994.sp020236","article-title":"The upregulation of acetylcholine release at endplates of alpha-bungarotoxin-treated rats: its dependency on calcium","volume":"478","author":"Plomp","year":"1994","journal-title":"J. Physiol."},{"key":"10.1016\/j.expneurol.2015.01.007_bb0435","doi-asserted-by":"crossref","first-page":"627","DOI":"10.1002\/ana.410370513","article-title":"Acetylcholine release in myasthenia gravis: regulation at single end-plate level","volume":"37","author":"Plomp","year":"1995","journal-title":"Ann. Neurol."},{"key":"10.1016\/j.expneurol.2015.01.007_bb0450","doi-asserted-by":"crossref","first-page":"111","DOI":"10.1002\/mus.20515","article-title":"Cholinergic neuromuscular hyperactivity in patients with myasthenia gravis seropositive for MuSK antibody","volume":"34","author":"Punga","year":"2006","journal-title":"Muscle Nerve"},{"key":"10.1016\/j.expneurol.2015.01.007_bb0455","doi-asserted-by":"crossref","first-page":"207","DOI":"10.1016\/j.expneurol.2011.04.018","article-title":"Muscle-selective synaptic disassembly and reorganization in MuSK antibody positive MG mice","volume":"230","author":"Punga","year":"2011","journal-title":"Exp. Neurol."},{"key":"10.1016\/j.expneurol.2015.01.007_bb0460","doi-asserted-by":"crossref","first-page":"558","DOI":"10.1097\/WCO.0000000000000136","article-title":"Clinical and scientific aspects of muscle-specific tyrosine kinase-related myasthenia gravis","volume":"27","author":"Reddel","year":"2014","journal-title":"Curr. Opin. Neurol."},{"key":"10.1016\/j.expneurol.2015.01.007_bb0465","doi-asserted-by":"crossref","first-page":"738","DOI":"10.1038\/286738a0","article-title":"Monoclonal anti-acetylcholine receptor antibodies can cause experimental myasthenia","volume":"286","author":"Richman","year":"1980","journal-title":"Nature"},{"key":"10.1016\/j.expneurol.2015.01.007_bb0470","doi-asserted-by":"crossref","first-page":"453","DOI":"10.1001\/archneurol.2011.2200","article-title":"Acute severe animal model of anti-muscle-specific kinase myasthenia: combined postsynaptic and presynaptic changes","volume":"69","author":"Richman","year":"2012","journal-title":"Arch. Neurol."},{"key":"10.1016\/j.expneurol.2015.01.007_bb0475","first-page":"82","article-title":"Acetylcholine receptor antibody in myasthenia gravis: predominance of IgG subclasses 1 and 3","volume":"67","author":"Rodgaard","year":"1987","journal-title":"Clin. Exp. Immunol."},{"key":"10.1016\/j.expneurol.2015.01.007_bb0480","doi-asserted-by":"crossref","first-page":"2234","DOI":"10.1007\/s00415-014-7520-7","article-title":"Inherited disorders of the neuromuscular junction: an update","volume":"261","author":"Rodriguez Cruz","year":"2014","journal-title":"J. Neurol."},{"key":"10.1016\/j.expneurol.2015.01.007_bb0485","doi-asserted-by":"crossref","first-page":"3163","DOI":"10.1113\/jphysiol.2008.153569","article-title":"Recovery of mouse neuromuscular junctions from single and repeated injections of botulinum neurotoxin A","volume":"586","author":"Rogozhin","year":"2008","journal-title":"J. Physiol."},{"key":"10.1016\/j.expneurol.2015.01.007_bb0490","doi-asserted-by":"crossref","first-page":"854","DOI":"10.1002\/mus.22177","article-title":"Endplate contributions to the safety factor for neuromuscular transmission","volume":"44","author":"Ruff","year":"2011","journal-title":"Muscle Nerve"},{"key":"10.1016\/j.expneurol.2015.01.007_bb0495","doi-asserted-by":"crossref","first-page":"370","DOI":"10.1002\/ana.410430315","article-title":"End-plate voltage-gated sodium channels are lost in clinical and experimental myasthenia gravis","volume":"43","author":"Ruff","year":"1998","journal-title":"Ann. Neurol."},{"key":"10.1016\/j.expneurol.2015.01.007_bb0500","doi-asserted-by":"crossref","first-page":"1978","DOI":"10.1212\/01.WNL.0000065882.63904.53","article-title":"Clinical aspects of MuSK antibody positive seronegative MG","volume":"60","author":"Sanders","year":"2003","journal-title":"Neurology"},{"key":"10.1016\/j.expneurol.2015.01.007_bb0505","doi-asserted-by":"crossref","first-page":"599","DOI":"10.1126\/science.276.5312.599","article-title":"Maintenance of acetylcholine receptor number by neuregulins at the neuromuscular junction in vivo","volume":"276","author":"Sandrock","year":"1997","journal-title":"Science"},{"key":"10.1016\/j.expneurol.2015.01.007_bb0510","doi-asserted-by":"crossref","first-page":"955","DOI":"10.1126\/science.1145181","article-title":"Blockade of acetylcholine receptors: a model of myasthenia gravis","volume":"187","author":"Satyamurti","year":"1975","journal-title":"Science"},{"key":"10.1016\/j.expneurol.2015.01.007_bb0515","doi-asserted-by":"crossref","first-page":"1945","DOI":"10.1212\/01.WNL.0000128048.23930.1D","article-title":"Are MuSK antibodies the primary cause of myasthenic symptoms?","volume":"62","author":"Selcen","year":"2004","journal-title":"Neurology"},{"key":"10.1016\/j.expneurol.2015.01.007_bb0520","doi-asserted-by":"crossref","first-page":"5190","DOI":"10.1172\/JCI66039","article-title":"Antibodies against low-density lipoprotein receptor-related protein 4 induce myasthenia gravis","volume":"123","author":"Shen","year":"2013","journal-title":"J. Clin. Invest."},{"key":"10.1016\/j.expneurol.2015.01.007_bb0525","doi-asserted-by":"crossref","first-page":"1016","DOI":"10.1172\/JCI21545","article-title":"Induction of myasthenia by immunization against muscle-specific kinase","volume":"116","author":"Shigemoto","year":"2006","journal-title":"J. Clin. Invest."},{"key":"10.1016\/j.expneurol.2015.01.007_bb0530","doi-asserted-by":"crossref","first-page":"119","DOI":"10.3988\/jcn.2014.10.2.119","article-title":"Clinical and electrophysiologic responses to acetylcholinesterase inhibitors in MuSK-antibody-positive myasthenia gravis: evidence for cholinergic neuromuscular hyperactivity","volume":"10","author":"Shin","year":"2014","journal-title":"J. Clin. Neurol."},{"key":"10.1016\/j.expneurol.2015.01.007_bb0535","doi-asserted-by":"crossref","first-page":"289","DOI":"10.1002\/ana.20341","article-title":"Acetylcholine receptors loss and postsynaptic damage in MuSK antibody-positive myasthenia gravis","volume":"57","author":"Shiraishi","year":"2005","journal-title":"Ann. Neurol."},{"key":"10.1016\/j.expneurol.2015.01.007_bb0540","doi-asserted-by":"crossref","first-page":"408","DOI":"10.1111\/cei.12217","article-title":"Myasthenia gravis: an update for the clinician","volume":"175","author":"Sieb","year":"2014","journal-title":"Clin. Exp. Immunol."},{"key":"10.1016\/j.expneurol.2015.01.007_bb0545","doi-asserted-by":"crossref","first-page":"1189","DOI":"10.1152\/physrev.00015.2011","article-title":"End-plate acetylcholine receptor: structure, mechanism, pharmacology, and disease","volume":"92","author":"Sine","year":"2012","journal-title":"Physiol. Rev."},{"key":"10.1016\/j.expneurol.2015.01.007_bb0550","doi-asserted-by":"crossref","first-page":"505","DOI":"10.1023\/B:NEUR.0000020607.17881.9b","article-title":"Structural determinants of the reliability of synaptic transmission at the vertebrate neuromuscular junction","volume":"32","author":"Slater","year":"2003","journal-title":"J. Neurocytol."},{"key":"10.1016\/j.expneurol.2015.01.007_bb0555","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1196\/annals.1405.003","article-title":"Structural factors influencing the efficacy of neuromuscular transmission","volume":"1132","author":"Slater","year":"2008","journal-title":"Ann. N. Y. Acad. Sci."},{"issue":"Pt 2","key":"10.1016\/j.expneurol.2015.01.007_bb0560","first-page":"451","article-title":"Structure and function of neuromuscular junctions in the vastus lateralis of man. A motor point biopsy study of two groups of patients","volume":"115","author":"Slater","year":"1992","journal-title":"Brain"},{"key":"10.1016\/j.expneurol.2015.01.007_bb0565","doi-asserted-by":"crossref","first-page":"67","DOI":"10.1002\/ana.21536","article-title":"Novel complement inhibitor limits severity of experimentally myasthenia gravis","volume":"65","author":"Soltys","year":"2009","journal-title":"Ann. Neurol."},{"key":"10.1016\/j.expneurol.2015.01.007_bb0575","doi-asserted-by":"crossref","first-page":"404","DOI":"10.1196\/annals.1254.052","article-title":"Role of Munc18-1 in synaptic plasticity at the myasthenic neuromuscular junction","volume":"998","author":"Sons","year":"2003","journal-title":"Ann. N. Y. Acad. Sci."},{"key":"10.1016\/j.expneurol.2015.01.007_bb0570","doi-asserted-by":"crossref","first-page":"433","DOI":"10.1016\/j.neuroscience.2005.11.040","article-title":"Alpha-neurexins are required for efficient transmitter release and synaptic homeostasis at the mouse neuromuscular junction","volume":"138","author":"Sons","year":"2006","journal-title":"Neuroscience"},{"key":"10.1016\/j.expneurol.2015.01.007_bb0580","doi-asserted-by":"crossref","first-page":"331","DOI":"10.1002\/mus.21424","article-title":"Jitter recordings with concentric needle electrodes","volume":"40","author":"Stalberg","year":"2009","journal-title":"Muscle Nerve"},{"key":"10.1016\/j.expneurol.2015.01.007_bb0585","doi-asserted-by":"crossref","first-page":"675","DOI":"10.1016\/j.neuron.2013.10.022","article-title":"Neurotransmitter release: the last millisecond in the life of a synaptic vesicle","volume":"80","author":"Sudhof","year":"2013","journal-title":"Neuron"},{"key":"10.1016\/j.expneurol.2015.01.007_bb0590","doi-asserted-by":"crossref","first-page":"785","DOI":"10.1016\/j.cell.2006.03.040","article-title":"Miniature neurotransmission stabilizes synaptic function via tonic suppression of local dendritic protein synthesis","volume":"125","author":"Sutton","year":"2006","journal-title":"Cell"},{"key":"10.1016\/j.expneurol.2015.01.007_bb0595","doi-asserted-by":"crossref","first-page":"e33333","DOI":"10.1371\/journal.pone.0033333","article-title":"Regulation of synaptic vesicle docking by different classes of macromolecules in active zone material","volume":"7","author":"Szule","year":"2012","journal-title":"PLoS One"},{"key":"10.1016\/j.expneurol.2015.01.007_bb0600","doi-asserted-by":"crossref","first-page":"128","DOI":"10.1038\/256128a0","article-title":"Experimental autoimmune myasthenia induced in monkeys by purified acetylcholine receptor","volume":"256","author":"Tarrab-Hazdai","year":"1975","journal-title":"Nature"},{"key":"10.1016\/j.expneurol.2015.01.007_bb0605","doi-asserted-by":"crossref","first-page":"1098","DOI":"10.1016\/S1474-4422(11)70245-9","article-title":"Lambert\u2013Eaton myasthenic syndrome: from clinical characteristics to therapeutic strategies","volume":"10","author":"Titulaer","year":"2011","journal-title":"Lancet Neurol."},{"key":"10.1016\/j.expneurol.2015.01.007_bb0610","doi-asserted-by":"crossref","first-page":"397","DOI":"10.1126\/science.1179220","article-title":"Myasthenia gravis: passive transfer from man to mouse","volume":"190","author":"Toyka","year":"1975","journal-title":"Science"},{"key":"10.1016\/j.expneurol.2015.01.007_bb0615","doi-asserted-by":"crossref","first-page":"925","DOI":"10.1111\/j.1468-1331.2009.02624.x","article-title":"Epidemiological and immunological profile of muscle-specific kinase myasthenia gravis in Greece","volume":"16","author":"Tsiamalos","year":"2009","journal-title":"Eur. J. Neurol."},{"key":"10.1016\/j.expneurol.2015.01.007_bb0620","doi-asserted-by":"crossref","first-page":"1203","DOI":"10.1212\/WNL.30.11.1203","article-title":"Ultrastructural localization of acetylcholine receptor at the motor endplate: myasthenia gravis and other neuromuscular diseases","volume":"30","author":"Tsujihata","year":"1980","journal-title":"Neurology"},{"key":"10.1016\/j.expneurol.2015.01.007_bb0625","doi-asserted-by":"crossref","first-page":"904","DOI":"10.1016\/j.autrev.2013.03.003","article-title":"Complement associated pathogenic mechanisms in myasthenia gravis","volume":"12","author":"Tuzun","year":"2013","journal-title":"Autoimmun. Rev."},{"key":"10.1016\/j.expneurol.2015.01.007_bb0630","doi-asserted-by":"crossref","first-page":"155","DOI":"10.1016\/j.clim.2014.02.012","article-title":"Preferential production of IgG1, IL-4 and IL-10 in MuSK-immunized mice","volume":"151","author":"Ulusoy","year":"2014","journal-title":"Clin. Immunol."},{"key":"10.1016\/j.expneurol.2015.01.007_bb0635","doi-asserted-by":"crossref","first-page":"501","DOI":"10.1002\/mus.10426","article-title":"Stimulated single-fiber EMG of the frontalis and orbicularis oculi muscles in ocular myasthenia gravis","volume":"28","author":"Valls-Canals","year":"2003","journal-title":"Muscle Nerve"},{"key":"10.1016\/j.expneurol.2015.01.007_bb0640","doi-asserted-by":"crossref","first-page":"479","DOI":"10.1016\/S0022-5193(89)80110-9","article-title":"Synaptic current between neuromuscular junction folds","volume":"140","author":"Vautrin","year":"1989","journal-title":"J. Theor. Biol."},{"key":"10.1016\/j.expneurol.2015.01.007_bb0645","doi-asserted-by":"crossref","first-page":"918","DOI":"10.1016\/j.autrev.2013.03.001","article-title":"Pathophysiology of myasthenia gravis with antibodies to the acetylcholine receptor, muscle-specific kinase and low-density lipoprotein receptor-related protein 4","volume":"12","author":"Verschuuren","year":"2013","journal-title":"Autoimmun. Rev."},{"key":"10.1016\/j.expneurol.2015.01.007_bb0650","doi-asserted-by":"crossref","first-page":"506","DOI":"10.1016\/j.expneurol.2012.01.025","article-title":"Passive and active immunization models of MuSK-Ab positive myasthenia: electrophysiological evidence for pre and postsynaptic defects","volume":"234","author":"Viegas","year":"2012","journal-title":"Exp. Neurol."},{"key":"10.1016\/j.expneurol.2015.01.007_bb0660","first-page":"257","article-title":"Acetylcholine receptor antibody characteristics in myasthenia gravis. I. Patients with generalized myasthenia or disease restricted to ocular muscles","volume":"49","author":"Vincent","year":"1982","journal-title":"Clin. Exp. Immunol."},{"key":"10.1016\/j.expneurol.2015.01.007_bb0655","doi-asserted-by":"crossref","first-page":"84","DOI":"10.1196\/annals.1405.020","article-title":"Myasthenia gravis seronegative for acetylcholine receptor antibodies","volume":"1132","author":"Vincent","year":"2008","journal-title":"Ann. N. Y. Acad. Sci."},{"key":"10.1016\/j.expneurol.2015.01.007_bb0665","doi-asserted-by":"crossref","first-page":"616","DOI":"10.1016\/j.neuron.2014.07.003","article-title":"Endostatin is a trans-synaptic signal for homeostatic synaptic plasticity","volume":"83","author":"Wang","year":"2014","journal-title":"Neuron"},{"key":"10.1016\/j.expneurol.2015.01.007_bb0670","doi-asserted-by":"crossref","first-page":"298","DOI":"10.1097\/00000542-197910000-00004","article-title":"Decrease in dose requirement of d-tubocurarine by volatile anesthetics","volume":"51","author":"Waud","year":"1979","journal-title":"Anesthesiology"},{"issue":"Pt 2","key":"10.1016\/j.expneurol.2015.01.007_bb0675","doi-asserted-by":"crossref","first-page":"401","DOI":"10.1113\/jphysiol.1995.sp020821","article-title":"Action potential generation in rat slow- and fast-twitch muscles","volume":"486","author":"Wood","year":"1995","journal-title":"J. Physiol."},{"issue":"Pt 1","key":"10.1016\/j.expneurol.2015.01.007_bb0680","doi-asserted-by":"crossref","first-page":"165","DOI":"10.1113\/jphysiol.1997.sp022007","article-title":"The contribution of postsynaptic folds to the safety factor for neuromuscular transmission in rat fast- and slow-twitch muscles","volume":"500","author":"Wood","year":"1997","journal-title":"J. Physiol."},{"key":"10.1016\/j.expneurol.2015.01.007_bb0685","doi-asserted-by":"crossref","first-page":"393","DOI":"10.1016\/S0301-0082(00)00055-1","article-title":"Safety factor at the neuromuscular junction","volume":"64","author":"Wood","year":"2001","journal-title":"Prog. Neurobiol."},{"key":"10.1016\/j.expneurol.2015.01.007_bb0690","doi-asserted-by":"crossref","first-page":"15.8.1","DOI":"10.1002\/0471142735.im1508s100","article-title":"Experimental autoimmune myasthenia gravis in the mouse","volume":"Unit 15","author":"Wu","year":"2013","journal-title":"Curr. Protoc. Immunol."},{"key":"10.1016\/j.expneurol.2015.01.007_bb0695","doi-asserted-by":"crossref","first-page":"655","DOI":"10.1016\/j.neuroscience.2006.09.022","article-title":"Delayed synapsing muscles are more severely affected in an experimental model of MuSK-induced myasthenia gravis","volume":"143","author":"Xu","year":"2006","journal-title":"Neuroscience"},{"key":"10.1016\/j.expneurol.2015.01.007_bb0705","doi-asserted-by":"crossref","first-page":"445","DOI":"10.1001\/archneurol.2011.2393","article-title":"Autoantibodies to lipoprotein-related protein 4 in patients with double-seronegative myasthenia gravis","volume":"69","author":"Zhang","year":"2012","journal-title":"Arch. Neurol."},{"key":"10.1016\/j.expneurol.2015.01.007_bb0700","doi-asserted-by":"crossref","first-page":"e91816","DOI":"10.1371\/journal.pone.0091816","article-title":"Autoantibodies to agrin in myasthenia gravis patients","volume":"9","author":"Zhang","year":"2014","journal-title":"PLoS One"},{"key":"10.1016\/j.expneurol.2015.01.007_bb0710","doi-asserted-by":"crossref","first-page":"8562","DOI":"10.4049\/jimmunol.179.12.8562","article-title":"Anti-C5 antibody treatment ameliorates weakness in experimentally acquired myasthenia gravis","volume":"179","author":"Zhou","year":"2007","journal-title":"J. Immunol."},{"key":"10.1016\/j.expneurol.2015.01.007_bb0715","doi-asserted-by":"crossref","first-page":"885","DOI":"10.1016\/j.neuroscience.2008.08.034","article-title":"Neuromuscular synaptic function in mice lacking major subsets of gangliosides","volume":"156","author":"Zitman","year":"2008","journal-title":"Neuroscience"}],"container-title":["Experimental Neurology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0014488615000138?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0014488615000138?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2020,5,14]],"date-time":"2020-05-14T17:50:46Z","timestamp":1589478646000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0014488615000138"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2015,8]]},"references-count":144,"alternative-id":["S0014488615000138"],"URL":"https:\/\/doi.org\/10.1016\/j.expneurol.2015.01.007","relation":{},"ISSN":["0014-4886"],"issn-type":[{"value":"0014-4886","type":"print"}],"subject":[],"published":{"date-parts":[[2015,8]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Electrophysiological analysis of neuromuscular synaptic function in myasthenia gravis patients and animal models","name":"articletitle","label":"Article Title"},{"value":"Experimental Neurology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.expneurol.2015.01.007","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"Copyright \u00a9 2015 Elsevier Inc. All rights reserved.","name":"copyright","label":"Copyright"}]}}